From: Characterization of adjacent breast tumors using oligonucleotide microarrays
Tumor | |||
---|---|---|---|
Gene | 5A/5B | 5A/7 | 5A/9 |
ER | NC | D(12.7) | NC |
PR | NC | NC | I(2.7) |
Androgen receptor | NC | NC | D(2.5) |
Epidermal growth factor receptor | NC | NC | NC |
ERBB2 | NC | NC | NC |
VEGF | NC | I(2.0) | D(2.2) |
TP53 | NC | NC | NC |
Ataxia telangiectasia (ATM) | NC | NC | NC |
FHIT | NC | NC | NC |
BRCA2 | NC | NC | NC |
RAD50 | NC | NC | NC |
BARD-1 | NC | D(2.9) | D(3.5) |
Retinoblastoma-1 (RB1) | NC | NC | NC |
Amplified in breast cancer (AIB1) | NC | NC | NC |
Breast cancer transcription | NC | NC | NC |
factor (ZaBCl) | |||
Thymidylate synthetase | NC | D(3.0) | NC |
Multidrug resistance gene (MDR-1) | NC | NC | NC |
Thrombospondin-1 | NC | NC | D(2.2) |
KI-67 antigen | NC | NC | NC |
Breast epithelial antigen (BA46) | NC | I(4.3) | NC |
Human mammaglobin | NC | I(3.6) | I(36.9) |
Human mammaglobin β precursor | I(40.1) | NC | I(29.1) |